Filing Flows › Comparisons › IGC vs PTN
IGC Pharma vs Palatin Technologies: IGC and PTN compared
IGC Pharma is the larger company: $328K of revenue in its latest quarter (Q3 2026) against $301K for Palatin Technologies (Q4 FY26).
Where the money goes: IGC and PTN
IGC Pharma (IGC) · Q3 2026
IGC Pharma, Q3 2026: revenue $328K (+72% year over year), operating margin -588.7%, net loss $2.0M, operating cash flow −$1.4M. The chart follows the revenue to costs, profit and cash.
Palatin Technologies (PTN) · Q4 FY26
Palatin Technologies, Q4 FY26: revenue $301K, net loss $4.4M, operating cash flow −$2.7M. The chart follows the revenue to costs, profit and cash.
| IGC Pharma (IGC) | Palatin Technologies (PTN) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q4 FY26 |
| Revenue | $328K | $301K |
| Revenue growth, Y/Y | +72% | — |
| Operating margin | -588.7% | n/m |
| Net earnings | −$2.0M | −$4.4M |
| Net margin | -623.8% | — |
| Operating cash flow | −$1.4M | −$2.7M |
Where the revenue comes from
IGC Pharma
- White Labeling Services: $321K (98%)
- Wellness and Lifestyle: $7K (2%)
Questions
Which is bigger, IGC Pharma or Palatin Technologies?
IGC Pharma is the larger company: $328K of revenue in its latest quarter (Q3 2026) against $301K for Palatin Technologies (Q4 FY26).
More: IGC Pharma earnings · how IGC Pharma makes money · Palatin Technologies earnings · how Palatin Technologies makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 6, 2026; 10-K filed Sep 28, 2026). Fiscal quarters can end on different dates. Not investment advice.